CD8A and neoplasm: For instance, PD-1 blockade induces Ki67 expression in a subset of peripheral PD-1+CD8+ T cells and the expansion of neoantigen-specific T cell clones after anti-PD-1 treatment, which suggests the restoration of systematic anti-tumor immunity of CD8+ T cells after receiving ICI immunotherapy (8, 9).